This site is intended for health professionals only!

Published on 8 December 2011

Share this story:
Twitter
LinkedIn
RELATED ARTICLES
Roche defends costs of cancer drug
Continuous chemotherapy improves outcomes and quality of life in advanced breast cancer
Cannabis “cuts cancer pain by 30%”
Stents’ eluting efficacy “remains stable”
UCB collaborates in the MetaHIT Project to decipher the human metagenome

Botulinum toxin A: practice recommendations in France

teaser

Maryvonne Villart, Delphine Pozzi, Kamel Hamami

University Hospital

Raymond Poincar



Most read

1
Feedback: Automation systems in your hospital
2
Helapet introduce new, improved 20mm Vented Vial Adapter
3
User-friendly osteoporosis therapy launched
4
Merck agrees huge Vioxx settlement
5
Janssen-Cilag’s Stelara approved by NICE



Latest Issue

Read the latest issue >
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
Share this story:
Twitter
LinkedIn
RELATED ARTICLES
Drug incompatibilities: a problem in clinical practice
Multiple sclerosis: drugs for symptomatic treatment
Colon cancer drug “boosts survival”
Tamiflu side effects reported
Ignore Tamiflu expiry date: experts